Xcout Intel
Attralus, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Attralus, Inc. among biotechnology companies — ranked by similarity to what Attralus, Inc. actually does, not by market-cap band.
Subscribe to see Attralus, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Attralus, Inc.
Attralus, Inc. is a biopharmaceutical company headquartered in Naples, Florida, focused on creating transformative medicines and novel pan-amyloid removal therapeutics and diagnostics.
Attralus, Inc. at a glance
Attralus, Inc. is a biotechnology company headquartered in United States. It has raised at least $197.6M across the 3 funding rounds on record. Its most recent funding round raised $56M in January 2024. Xcout tracks 15 named people at Attralus, Inc., including Mark Timney (CHIEF EXECUTIVE OFFICER).
Attralus, Inc. leadership
- Mark TimneyCHIEF EXECUTIVE OFFICER
- Glen FirestoneCHIEF BUSINESS OFFICER
- Gregory BellCHIEF MEDICAL OFFICER
- Jonathan WallCO-FOUNDER & INTERIM CHIEF SCIENTIFIC OFFICER
- Karen RobertsonVICE PRESIDENT, REGULATORY AFFAIRS
- Nicolas Angell, PhDVICE PRESIDENT, CMC
9 more named people on record for Attralus, Inc., with roles, board committees and tenure — see the full roster →
Attralus, Inc. funding rounds
At least $197.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $56M | 9 named | |
| Series B | $116.6M | 8 named | |
| Series A | $25M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Attralus, Inc. competitors
Ranked by semantic similarity — how close each company is to Attralus, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Attune Biotech Inc. is a biopharmaceutical company that develops novel medicines to treat underserved disorders, focusing on neuroimmune, inflammatory, infectious disease, and metabolic applications. The company utilizes a proprietary platform approach featuring its flagship candidate, Lodonal, which is engineered with pharmaceutical-grade consistency and precision dosing to restore immune balance.
Biotech
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Similar biotechnology company
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Similar biotechnology company
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
Similar biotechnology company
Sironax is a biopharmaceutical company committed to developing new treatments by targeting underlying contributors of degeneration, including neurodegenerative, inflammatory, and metabolic disorders.
Similar biotechnology company
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Similar biotechnology company
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Life Sciences
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Similar biotechnology company
Ultimate Medicine AG is a Swiss preclinical biotechnology company headquartered in Zürich, focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias by targeting novel toxic metabolites.
Similar biotechnology company
Autobahn Therapeutics is a biotechnology company headquartered in San Diego, California, focused on developing restorative treatments in the medical sector.
Biotech
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Similar biotechnology company
Jupiter Biomedical Research, Inc. is a biomedical research company founded in 2016 and located in Palm Beach Gardens, Florida. The company is focused on developing innovative drug candidates to treat serious diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Attralus, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Attralus, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →